GlobeNewsWire
18 Jun 2026, 12:44 UTC · 12w ago
Verdict
Headline takes no side. We score BMI −1.00 across three claims — strongly bearish.
−1.00strongly bearish
More negative than 95% of ticker scores this week
What the story claims
3 claims · scored −1 bearish … +1 bullish
ADMA Biologics is accused of a channel-stuffing scheme to report 20% revenue growth in 2025 when actual growth was allegedly -3%.
So whatAllegations of systemic financial manipulation and artificial revenue inflation typically lead to severe valuation resets and loss of investor trust.
More negative than 99% of claims this week
Berger Montague PC has filed a class action lawsuit against ADMA Biologics on behalf of investors for the period from August 9, 2024, through March 25, 2026.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Top 1 mover · tap to explore
More negative than 86% of claims this week
The lawsuit alleges that ADMA Biologics failed to disclose related party transactions involving a distributor.
More negative than 80% of claims this week
Which stocks this story touches
More negative than 95% of ticker scores this week
The company is the subject of a class action lawsuit announced by Berger Montague.
More negative than 95% of ticker scores this week
The company is facing a class action lawsuit alleging a channel-stuffing scheme to inflate revenue growth.
More negative than 95% of ticker scores this week
The company is the subject of a class action lawsuit announced by Berger Montague.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
GlobeNewsWire
2d ago
−5.7%
Price agrees with the score
$126.91 vs $134.65 close before publication (Jun 17) · not market-adjusted
BMI chart →
